Thermo Fisher: A Growing Company With An Acquisition Strategy

|
About: Thermo Fisher Scientific Inc. (TMO)
by: Kurt Pollet
This article is exclusive for subscribers.
Kurt Pollet
Growth, momentum, portfolio strategy, newsletter provider
Summary

Thermo Fisher is a profitable company with moderate debt levels.

The company’s earnings have shown strong growth over the last five years with more growth expected for 2020.

Management is proactive and will divest any business unit that underperforms and replace it with new acquisitions that have the potential to perform.

Thermo Fisher sees further growth opportunities in China.

Introduction

Thermo Fisher Scientific Inc. (TMO) is a global company in the medical research industry providing instruments, equipment and software. The company’s has shown solid growth over the years and more growth is